Sep 18, 2017   SOURCE: BusinessWire

Stevioside Market in China 2017-2022 - Research and Markets

The "Stevioside Market in China 2017-2022" report has been added to Research and Markets' offering.

Although stevioside has a long history in South America, China is the major producer, taking 90% of the global capacity, making it the largest planter of stevia rebaudiana, the largest producer and exporter of stevioside. More than 70% of stevioside produced in China is exported, which means overseas demand has bigger influence on the country's output. In 2016, the output of stevioside in the country reached nearly 8,000 tonnes.

In the future, stevioside will be affected by per capita consumption of zero-calorie beverages and new stevioside products will cost less and will benefit people's health. Emerging markets and developing regions create opportunities for investors. Because stevioside has a zero glycemic index and zero calorie, it is popular in many countries.

In recent years, stevioside has replaced some other sweeteners in food, medicine and daily chemical industries, driving continuously rising demand for the sweetener and providing more space for leading enterprises in the industry. At the same time, along with the downstream development, the demand for high-purity stevioside will increase as well, which brings new profits to manufacturers with innovative ability. In 2022, the sales volume of stevioside is forecasted to reach about 4,000 tonnes and the market scale will be around RMB3.4 billion.

Key Topics Covered:

1 Development Environment for Stevioside Industry in China

1.1 Economy

1.2 Policy

1.3 General Development Analysis of Plant Extracts in China

2 General Status of China Stevioside Market, 2012-2016

2.1 Supply

2.2 Market Scale

2.3 Demand

2.4 Price

2.5 Export

3 Industrial Chain of Stevioside in China

3.1 Planting Area of Stevia Rebaudiana

3.2 Downstream

4 Analysis of Key Stevioside Enterprises in China

4.1 PureCircle (Jiangxi) Co. Ltd.

4.2 Zhucheng Haotian Pharm Co., Ltd.

4.3 Qufu Lvtianyuan High Technology Co., Ltd

4.4 Biolotus Technology Jiangsu Inc.

4.3 Chenguang Biotech Group Co., Ltd.

5 Forecast and Investment Suggestions of Stevioside Industry in China, 2017-2022

5.1 Forecast

5.2 Investment Suggestion

For more information about this report visit https://www.researchandmarkets.com/research/xjwtjl/stevioside_market